Dr. David Fajgenbaum is the Executive Director and cofounder of the Castleman Disease Collaborative Network, whose mission is to accelerate research, treatment and patient care through global collaboration, strategic investments in research and support for patients and their loved ones. Castleman disease is a rare disorder involving proliferation of cells in the body’s lymphatic, or immune, system. David and CDCN have taken an innovative approach to overcome many hurdles.